WhatsApp Channel Join Now
Telegram Group Join Now
| Relevance: GS-II Health Governance & Policies · GS-III Supply Chains | Source: Drugs (Fifth Amendment) Rules, 2026 |
1 · What happened
|
You can no longer buy a cough syrup in India without a doctor’s prescription. The Union Health Ministry announced this change on 9 June 2026. Why now? Because of a string of tragedies. In late 2025, around 20+ children died in Madhya Pradesh and Rajasthan after taking a contaminated cough syrup — echoing earlier child deaths abroad in the Gambia, Uzbekistan and Cameroon (2022–23) linked to India-made syrups. |
2 · The rule, in simple terms
| Schedule K is a list (in the Drugs Rules, 1945) of medicines that get certain relaxations — small comforts so common remedies reach far-flung places easily. Cough syrups were on that list. |
- Before: syrups could be sold even in small villages (under 1,000 people) without a full pharmacy licence.
- The change: the word “Syrups” was removed from Schedule K through the Drugs (Fifth Amendment) Rules, 2026 (a draft had been floated in December 2025).
- Now: syrups can be sold only through licensed pharmacies, on a doctor’s prescription.
3 · Why cough syrups can be dangerous
| The poison problem. The deaths were caused by ethylene glycol (EG) and diethylene glycol (DEG) — cheap, toxic industrial solvents that should never be in medicine. Sometimes used as a cheaper substitute, even a few spoonfuls can cause kidney failure and death in children. |
- Risky “cocktails”: many over-the-counter (OTC) syrups mix several drugs at once, which can cause tremors, a racing heart, or heavy drowsiness in small children.
- Not for the young: the American Academy of Pediatrics warns cough suppressants are largely useless and unsafe for children under six, and can hide serious illnesses like pneumonia.
- The OTC habit: in many rural areas people skip the doctor and ask the chemist directly — so the pharmacist becomes the de facto doctor.
4 · The real debate: is this the right fix?
Critics call the prescription rule a “lopsided” fix — it controls how patients buy the medicine, but not how it is made. Four pieces of the puzzle:
|
The root cause
It starts in the factory
The poisoning came from poor quality control and untested raw materials — not from how patients bought the syrup. A prescription cannot stop a bad batch leaving the plant.
|
The government’s step
Control the counter
Making syrups prescription-only adds a check at the point of sale — useful, but it tackles the consumer end, not the source.
|
|
The obstacles
Cost vs safety
Strict testing is resisted on the plea it would bankrupt small makers. And enforcement is thin — India has only about three dozen state drug controllers, badly understaffed.
|
The real fix
Test every batch
Make raw-material and batch testing compulsory, punish makers who skip it, upgrade state labs, and hire many more inspectors.
|
| UPSC Value Box | ||||||||||||||
|
| MCQ Practice Question |
Q. With reference to drug regulation in India, consider the following statements:
Which of the statements given above is/are correct? |
Answer: (c) 1 and 3 only
|
Start Yours at Ajmal IAS – with Mentorship StrategyDisciplineClarityResults that Drives Success
Your dream deserves this moment — begin it here.
